Top

Published in:

Open Access 01-02-2010 | Review Article

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review

Authors: Marina Danckaerts, Edmund J. S. Sonuga-Barke, Tobias Banaschewski, Jan Buitelaar, Manfred Döpfner, Chris Hollis, Paramala Santosh, Aribert Rothenberger, Joseph Sergeant, Hans-Christoph Steinhausen, Eric Taylor, Alessandro Zuddas, David Coghill

Published in: European Child & Adolescent Psychiatry | Issue 2/2010

Abstract

Quality of life (QoL) describes an individual’s subjective perception of their position in life as evidenced by their physical, psychological, and social functioning. QoL has become an increasingly important measure of outcome in child mental health clinical work and research. Here we provide a systematic review of QoL studies in children and young people with attention deficit hyperactivity disorder (ADHD) and address three main questions. (1) What is the impact of ADHD on QoL? (2) What are the relationships between ADHD symptoms, functional impairment and the mediators and moderators of QoL in ADHD? (3) Does the treatment of ADHD impact on QoL? Databases were systematically searched to identify research studies describing QoL in ADHD. Thirty six relevant articles were identified. Robust negative effects on QoL are reported by the parents of children with ADHD across a broad range of psycho-social, achievement and self evaluation domains. Children with ADHD rate their own QoL less negatively than their parents and do not always seeing themselves as functioning less well than healthy controls. ADHD has a comparable overall impact on QoL compared to other mental health conditions and severe physical disorders. Increased symptom level and impairment predicts poorer QoL. The presence of comorbid conditions or psychosocial stressors helps explain these effects. There is emerging evidence that QoL improves with effective treatment. In conclusion, ADHD seriously compromises QoL especially when seen from a parents’ perspective. QoL outcomes should be included as a matter of course in future treatment studies.

American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV TR). The Press, Washington (DC)

August GJ, Braswell L, Thuras P (1998) Diagnostic stability of ADHD in a community sample of school-aged children screened for disruptive behavior. J Abnorm Child Psychol 26:345–356CrossRefPubMed

Bagwell CL, Molina BS, Pelham WE Jr, Hoza B (2001) Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry 40:1285–1292CrossRefPubMed

Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476–495CrossRefPubMed

Barkley RA, Fischer M, Smallish L, Fletcher K (2006) Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45:192–202CrossRefPubMed

Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1990) Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86:184–192PubMed

Bastiaansen D, Koot HM, Ferdinand RF, Verhulst FC (2004) Quality of life in children with psychiatric disorders: self-, parent, and clinician report. J Am Acad Child Adolesc Psychiatry 43(2):221–230CrossRefPubMed

Bastiaansen D, Koot HM, Ferdinand RF (2005) Psychopathology in children: improvement of quality of life without psychiatric symptom reduction? Eur Child Adoles Psychiatry 14(7):364–370CrossRef

Berkson J (1946) Limitations of the application of the fourfold table analysis to hospital data. Biometrics 2:47–53CrossRef

10.

Bibace R, Walsh ME (1980) Development of children’s concepts of illness. Pediatrics 66:912–917PubMed

11.

Biederman J, Faraone SV, Lapey K (1992) Comorbidity of diagnosis in attention-deficit hyperactivity disorder. Child Adolesc Psychiatric Clin N A 1:335–360

12.

Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV (2006) Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 36:167–179CrossRefPubMed

13.

Biederman J, Spencer TJ, Newcorn JH, Gao H, Milton DR, Feldman PD, Witte MM (2007) Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology (Berl) 190:31–41CrossRef

14.

Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T (1998) Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 44:269–273CrossRefPubMed

15.

Brown RT, Perwien A, Faries DE, Kratochvil CJ, Vaughan BS (2006) Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning. Clin Pediatr (Phila) 45:819–827CrossRef

16.

Cheng JY, Chen RY, Ko JS, Ng EM (2007) Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl) 194:197–209CrossRef

17.

Christie MJ, French D, Sowden A, West A (1993) Development of child-centered disease-specific questionnaires for living with asthma. Psychosom Med 55:541–548PubMed

18.

Coghill D, Danckaerts M, Sonuga-Barke E, Sergeant J, the ADHD European Guidelines Group (2008) Practitioner review: quality of life in child mental health—conceptual challenges and practical choices. J Child Psychol Psychiatry 50(5):544–561

19.

Coghill D, Spender Q, Barton J, Hollis C, Yuen C, Cleemput L, Annemans L (2004) Measuring quality of life in children with attention-deficit-hyperactivity disorder in the UK. Poster presented at International Association for Child and Adolescent Psychiatry and Allied Professions, Berlin, Germany

20.

DeVeaugh-Geiss J, Conners CK, Sarkis EH, Winner PK, Ginsberg LD, Hemphill JM, Laurenza A, Barrows CE, Webster CJ, Stotka CJ, Asgharnejad M (2002) GW320659 for the treatment of attention-deficit/hyperactivity disorder in children. J Am Acad Child Adolesc Psychiatry 41:914–920CrossRefPubMed

21.

Dolan P (2000) The measurement of health-related quality of life for use in resource allocation decisions in health care. In: Culyer AJ, Newhouse JP (eds) Handbook of Health Economics. Elsevier, North-Holland, pp 1723–1760

22.

Edwards TC, Huebner CE, Connell FA, Patrick DL (2002) Adolescent quality of life, part I: conceptual and measurement model. J Adolesc 25:275–286CrossRefPubMed

23.

Eiser C, Cotter I, Oades P, Seamark D, Smith R (1999) Health-related quality-of-life measures for children. Int J Cancer Suppl 12:87–90CrossRefPubMed

24.

Eiser C, Morse R (2001) Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 5:1–157PubMed

25.

Erhardt D, Hinshaw SP (1994) Initial sociometric impressions of attention-deficit hyperactivity disorder and comparison boys: predictions from social behaviors and from nonbehavioral variables. J Consult Clin Psychol 62:833–842CrossRefPubMed

26.

Escobar R, Soutullo CA, Hervas A, Gastaminza X, Polavieja P, Gilaberte I (2005) Worse quality of life for children with newly diagnosed attention-deficit/hyperactivity disorder, compared with asthmatic and healthy children. [erratum appears in Pediatrics. 2005 Nov;116(5):1266]. Pediatrics 116(3):e364–e369CrossRefPubMed

27.

EuroQol Group (1990) EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 16:199–208CrossRef

28.

Flapper BC, Schoemaker MM, Flapper Boudien CT, Schoemaker Marina M (2008) Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Develop Med Child Neurol 50:294–299CrossRefPubMed

29.

Graetz BW, Sawyer MG, Hazell PL, Arney F, Baghurst P (2001) Validity of DSM-IVADHD subtypes in a nationally representative sample of Australian children and adolescents. J Am Acad Child Adolesc Psychiatry 40:1410–1417CrossRefPubMed

30.

Graham J, Coghill D (2008) Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs 22:213–237CrossRefPubMed

31.

Gringras P, Santosh P, Baird G (2006) Development of an Internet-based real-time system for monitoring pharmacological interventions in children with neurodevelopmental and neuropsychiatric disorders. Child Care Health Dev 32(5):591–600CrossRefPubMed

32.

Hakkaart-van Roijen L, Zwirs BWC, Bouwmans C, Tan SS, Schulpen TWJ, Vlasveld L, Buitelaar JK (2007) Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 16(5):316–326CrossRefPubMed

33.

Hampel P, Desman C (2006) Coping and quality of life among children and adolescents with attention deficit/hyperactivity disorder. Prax Kinderpsychol Kinderpsychiatr 55:425–443PubMed

34.

Harter S, Pike R (1984) The pictorial scale of perceived competence and social acceptance for young children. Child Dev 55:1969–1982CrossRefPubMed

35.

Hoza B, Pelham WE Jr, Dobbs J, Owens JS, Pillow DR (2002) Do boys with attention-deficit/hyperactivity disorder have positive illusory self-concepts? J Abnorm Psychol 111:268–278CrossRefPubMed

36.

Juniper EF, Guyatt GH, Feeny DH, Griffith LE, Ferrie PJ (1997) Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Eur Respir J 10:2285–2294CrossRefPubMed

37.

Klassen AF (2005) Quality of Life of children with attention deficit hyperactivity disorder. Expert Rev Pharmacoecon Outcomes Res 5:95–103CrossRefPubMed

38.

Klassen AF, Miller A, Fine S (2004) Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics 114(5):e541–e547CrossRefPubMed

39.

Klassen AF, Miller A, Fine S (2006) Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder. [References]. Child Care Health Dev 32:397–406CrossRefPubMed

40.

Kolsteren MM, Koopman HM, Schalekamp G, Mearin ML (2001) Health-related quality of life in children with celiac disease. J Pediatr 138:593–595CrossRefPubMed

41.

Landgraf JM, Abetz LN (1997) Functional status and well-being of children representing 3 cultural groups: initial self reports using the CHQ-CF87. Psychol Health 12:839–854CrossRef

42.

Landgraf JM, Abetz LN, Ware JE (1999) The CHQ users manual. Boston, Health Act, MA

43.

Landgraf JM, Rich M, Rappaport L (2002) Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. Arch Pediatr Adolesc Med 156:384–391PubMed

44.

Leidy NK, Rich M, Geneste B (1999) Recomendations for evaluating the validity of life claims for labeling and promotion. Value Health 2:113–127CrossRefPubMed

45.

Matza LS, Rentz AM, Secnik K, Swensen AR, Revicki DA, Michelson D, Spencer T, Newcorn JH, Kratochvil CJ (2004) The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr 25:166–174CrossRefPubMed

46.

Matza LS, Secnik K, Mannix S, Sallee FR (2005) Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. Pharmacoeconomics 23(8):777–790CrossRefPubMed

47.

Matza LS, Secnik K, Rentz AM, Mannix S, Sallee FR, Gilbert D, Revicki DA (2005) Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Qual Life Res 14:735–747PubMed

48.

Matza LS, Swensen AR, Flood EM, Secnik K, Leidy NK (2004) Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues. Value Health 7:79–92CrossRefPubMed

49.

Mize J, Ladd GW (1988) Predicting preschoolers peer behaviour and status from their interpersonal strategies—a comparison of verbal and enactive responses to hypothetical social situations. Develop Psychol 24:782–788CrossRef

50.

Moss MS, Hoffman CJ, Mossey J, Rovine M (2007) Changes over 4 years in health, quality of life, mental health, and valuation of life. J Aging Health 19:1025–1044CrossRefPubMed

51.

National Institute for Mental Health (1985) Clinical global impressions. Psychopharmacol Bull 21:839–843

52.

Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D (2005) Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry 44:240–248CrossRefPubMed

53.

Norman GR, Sloan JA, Wyrwich KW (2003) Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41:582–592CrossRefPubMed

54.

Ohan JL, Johnston C (2002) Are the performance overestimates given by boys with ADHD self-protective? J Clin Child Adolesc Psychol 31:230–241PubMed

55.

Owens JS, Hoza B (2003) The role of inattention and hyperactivity/impulsivity in the positive illusory bias. J Consult Clin Psychol 71:680–691CrossRefPubMed

56.

Patrick DL, Edwards TC, Topolski TD (2002) Adolescent quality of life, part II: initial validation of a new instrument. J Adolesc 25(3):287–300CrossRefPubMed

57.

Perwien AR, Faries DE, Kratochvil CJ, Sumner CR, Kelsey DK, Allen AJ (2004) Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine. [see comment]. J Develop Behav Pediatrics 25(4):264–271CrossRef

58.

Perwien AR, Kratochvil CJ, Faries DE, Vaughan BS, Spencer T, Brown RT (2006) Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-life outcomes? J Child Adolesc Psychopharmacol 16(6):713–724CrossRefPubMed

59.

Pongwilairat K, Louthrenoo O, Charnsil C, Witoonchart C (2005) Quality of life of children with attention-deficit/hyper activity disorder. J Med Assoc Thai 88(8):1062–1066PubMed

60.

Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K (2007) A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Curr Med Res Opin 23:379–394CrossRefPubMed

61.

Preuss U, Ralston SJ, Baldursson G, Falissard B, Lorenzo MJ, Rodrigues PR, Vlasveld L, Coghill D (2006) Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study. Eur Child Adolesc Psychiatry 15(Suppl 1):i4–i14CrossRefPubMed

62.

Ravens-Sieberer U, Bullinger M (1998) Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res 7:399–407CrossRefPubMed

63.

Rebok G, Riley A, Forrest C, Starfield B, Green B, Robertson J, Tambor E (2001) Elementary school-aged children’s reports of their health: a cognitive interviewing study. Qual Life Res 10:59–70CrossRefPubMed

64.

Rentz AM, Matza LS, Secnik K, Swensen A, Revicki DA (2005) Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder. Qual Life Res 14(3):719–734CrossRefPubMed

65.

Riley AW, Coghill D, Forrest CB, Lorenzo MJ, Ralston SJ, Spiel G (2006) Validity of the health-related quality of life assessment in the ADORE study: parent report form of the CHIP-Child Edition. Eur Child Adolesc Psychiatry 15(Suppl 1):i63–i71CrossRefPubMed

66.

Riley AW, Forrest CB, Rebok GW, Starfield B, Green BF, Robertson JA, Friello P (2004) The child report form of the CHIP-Child Edition: reliability and validity. Med Care 42:221–231CrossRefPubMed

67.

Riley AW, Forrest CB, Starfield B, Rebok G, Robertson JA, Green BF (2004) The parent report form of the CHIP-Child Edition: reliability and validity. Med Care 42:210–220CrossRefPubMed

68.

Riley AW, Spiel G, Coghill D, Dopfner M, Falissard B, Lorenzo MJ, Preuss U, Ralston SJ (2006) Factors related to Health-Related Quality of Life (HRQoL) among children with ADHD in Europe at entry into treatment. Eur.Child Adolesc.Psychiatry 15(Suppl 1):i38–i45CrossRefPubMed

69.

Rimmer M, Campbell C, Coghill D (2007) ADHD: the Impact on Parent’s and Children’s Quality of Life. Boston, American Academy of Child and Adolescent Psychiatry Annual Meeting

70.

Rudnick A (2001) The impact of coping on the relation between symptoms and quality of life in schizophrenia. Psychiatry 64:304–308PubMed

71.

Sallee FR, Ambrosini PJ, Lopez FA, Shi L, Michaels MA (2004) Health-related quality of life and treatment satisfaction and preference in a community assessment study of extended-release mixed amphetamine salts for children with attention-deficit/hyperactivity disorder. J Outcomes Res 2:7–49

72.

Satterfield J, Swanson J, Schell A, Lee F (1994) Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores. J Am Acad Child Adolesc Psychiatry 33:185–190CrossRefPubMed

73.

Satterfield JH, Schell A (1997) A prospective study of hyperactive boys with conduct problems and normal boys: adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry 36:1726–1735CrossRefPubMed

74.

Sawyer MG, Arney F, Baghurst P, Clark JJ, Graetz BW, Kosky RJ, Nurcombe B, Patton GC, Prior MR, Raphael B, Rey J, Whaites LC, Zubrick SR (2000) The Mental Health of Young People in Australia. Adelaide, Mental Health and Special Programs Branch, Commonwealth Department of Health and Aged Care

75.

Sawyer MG, Whaites L, Rey JM, Hazell PL, Graetz BW, Baghurst P (2002) Health-related quality of life of children and adolescents with mental disorders. J Am Acad Child Adolesc Psychiatry 41(5):530–537CrossRefPubMed

76.

Secnik K, Matza LS, Cottrell S, Edgell E, Tilden D, Mannix S (2005) Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United Kingdom. Med Decis Making 25:56–70CrossRefPubMed

77.

Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S (1983) A children’s global assessment scale (CGAS). Arch Gen Psychiatry 40:1228–1231PubMed

78.

Solans BS, Pane S, Estrada M-D, Serra-Sutton S, Berra S, Herdman M, Alonso J, Rajmil L (2008) Health-related quality of life measurement in children and adolescents: a systematic review of generic and disease-specific instruments. Value Health 11:742–764CrossRefPubMed

79.

Spitzer RL, Kroenke K, Linzer M, Hahn SR, Williams JB, deGruy FVIII, Brody D, Davies M (1995) Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA 274:1511–1517CrossRefPubMed

80.

Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A (2004) European clinical guidelines for hyperkinetic disorder–first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):I7–I30PubMed

81.

The ADORE Study Group. (2005) European ADHD Observational Study (ADORE): Longitudinal Results (baseline—3 months). Toronto, American Academy of Child and Adolescent Psychiatry Annual Meeting

82.

Topolski TD, Edwards TC, Patrick DL, Varley P, Way ME, Buesching DP (2004) Quality of life of adolescent males with attention-deficit hyperactivity disorder. J Atten Disord 7:163–173CrossRefPubMed

83.

Varni JW, Burwinkle TM (2006) The PedsQL as a patient-reported outcome in children and adolescents with Attention-Deficit/Hyperactivity Disorder: a population-based study. Health Qual Life Outcomes 4:26CrossRefPubMed

84.

Varni JW, Burwinkle CA, Limbers TM, Szer IS (2007) The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health Qual Life Outcomes 5:9CrossRefPubMed

85.

Varni JW, Seid M, Kurtin PS (2001) PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care 39:800–812CrossRefPubMed

86.

Varni JW, Seid M, Rode CA (1999) The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 37:126–139CrossRefPubMed

87.

Vogels T, Verrips GH, Verloove-Vanhorick SP, Fekkes M, Kamphuis RP, Koopman HM, Theunissen NC, Wit JM (1998) Measuring health-related quality of life in children: the development of the TACQOL parent form. Qual Life Res 7:457–465CrossRefPubMed

88.

Wehmeier PM, Dittmann RW, Schacht A, Minarzyk A, Lehmann M, Sevecke K, Lehmkuhl G, Wehmeier PM, Dittmann RW, Schacht A, Minarzyk A, Lehmann M, Sevecke K, Lehmkuhl G (2007) Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study. J Child Adolesc Psychopharmacol 17:813–830CrossRefPubMed

89.

Wehmeier PM, Schacht A, Dittmann RW, Dopfner M (2008) Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day. Child Adolesc Psychiatry Ment Health 2:10CrossRefPubMed

90.

Weiss MD, Brooks BL (2007) Clinical normative data for the Weiss Functional Impairment Rating Scale. American Academy of Child and Adolescent Psychiatry Annual Meeting, Boston

91.

WHOQOL (1995) World Health Organisation Quality of Life Assessment (WHOQOL): position paper from the World Health Organisation. Soc Sci Med 41:1403–1409CrossRef

92.

Wigal SB, Wigal TL, McGough JM, Kollins SH, Biederman JB, Posner KL (2005) A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR^®) and Atomoxetine (Strattera^®) in school-aged children with attention deficit/hyperactivity disorder. J Atten Disord 9:275–289CrossRefPubMed

93.

Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF (2005) Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57:1336–1346CrossRefPubMed

94.

Wilson JM, Marcotte AC (1996) Psychosocial adjustment and educational outcome in adolescents with a childhood diagnosis of attention deficit disorder. J Am Acad Child Adolesc Psychiatry 35:579–587CrossRefPubMed

95.

World Health Organisation (1947) World Health Organisation Constitution. World Health Organisation, Geneva

96.

World Health Organisation (1992) International Classification of Diseases (ICD-10). Geneva, WHO

97.

Yang P, Hsu HY, Chiou SS, Chao MC (2007) Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample. Aust N Z J Psychiatry 41:998–1004CrossRefPubMed

Title: The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
Authors: Marina Danckaerts
Edmund J. S. Sonuga-Barke
Tobias Banaschewski
Jan Buitelaar
Manfred Döpfner
Chris Hollis
Paramala Santosh
Aribert Rothenberger
Joseph Sergeant
Hans-Christoph Steinhausen
Eric Taylor
Alessandro Zuddas
David Coghill
Publication date: 01-02-2010
Publisher: D. Steinkopff-Verlag
Published in: European Child & Adolescent Psychiatry / Issue 2/2010
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-009-0046-3

At a glance: The STEP trials

Springer Medicine

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2010

Some clinical characteristics of children who survived the Marmara earthquakes

Mental health of adolescents reared in institutional care in Turkey: challenges and hope in the twenty-first century

Co-morbidity and patterns of care in stimulant-treated children with ADHD in the Netherlands

Erratum to: Screening for psychopathology in child welfare: the Strengths and Difficulties Questionnaire (SDQ) compared with the Achenbach System of Empirically Based Assessment (ASEBA)

The volumetric differences of the fronto-temporal region in young offspring of schizophrenic patients

Does ADHD moderate the manifestation of anxiety disorders in children?